Journal
CANADIAN JOURNAL OF CHEMISTRY
Volume 95, Issue 9, Pages 897-902Publisher
CANADIAN SCIENCE PUBLISHING
DOI: 10.1139/cjc-2017-0193
Keywords
dendrimer; ocular drug delivery; nanomedicine
Categories
Funding
- National Institutes of Health [R01EY024072]
Ask authors/readers for more resources
Existing methods of administering ocular drugs are limited in either their safety or efficiency. Nanomedicine therapies have the potential to address this deficiency by creating vehicles that can control drug biodistribution. Dendrimers are synthetic polymeric nanoparticles with a unique, highly organized branching structure. In recent years, promising results using dendrimer vehicles to deliver ocular drugs through different routes of administration have been reported. In this minireview, we briefly summarize these results with emphasis on the dendrimer modifications used to target different ocular structures.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available